Advent Access unveils Clinical Trial results at the American Society of Nephrology Kidney Week, 2018
The full results of Advent Access's First-In-Human Clinical Trial of the av-Guardian device was released at the American Society of Nephrology (ASN) Kidney Week 2018. The ASN is lauded as the most premier nephrology meeting, involving 13,000 nephrologists and the world’s leading experts discussing the latest advances in the field.
